Once-daily dolutegravir sufficient when taking TB treatment
Can testing for drug-gene interactions improve treatment success in people with HIV?
Good news for women and PrEP: quarterly dosing may work
Anticholinergic medications associated with falls and frailty in people ageing with HIV
One dose of TAF every three days gets more drug into cells than a daily dose of TDF
Studies confirm that hormone levels in trans women are not greatly affected by PrEP, or vice versa
Elderly women more likely than men to have inappropriately prescribed medicines
PrEP does not lower hormone levels in young transgender people, but lower PrEP levels seen in some transgender women
Doubling the dose of emergency contraception is a safe and effective way of overcoming efavirenz interaction
